Pierdomenico Laura, Bonsi Laura, Calvitti Mario, Rondelli Damiano, Arpinati Mario, Chirumbolo Gabriella, Becchetti Ennio, Marchionni Cosetta, Alviano Francesco, Fossati Valentina, Staffolani Nicola, Franchina Michele, Grossi Alberto, Bagnara Gian Paolo
Department of Histology, Embryology, and Applied Biology, University of Bologna, Bologna, Italy.
Transplantation. 2005 Sep 27;80(6):836-42. doi: 10.1097/01.tp.0000173794.72151.88.
Bone marrow mesenchymal stem cells (MSCs) are currently being investigated in preclinical and clinical settings because of their multipotent differentiative capacity or, alternatively, their immunosuppressive function. The aim of this study was to evaluate dental pulp (DP) as a potential source of MSCs instead of bone marrow (BM).
Flow cytometric analysis showed that DP-MSCs and BM-MSCs were equally SH2, SH3, SH4, CD29 and CD 166 positive. The in vitro proliferative kinetics of MSCs were measured by 3H-thymidine incorporation uptake. The immunosuppressive function of MSCs was then tested by coculturing PHA-stimulated allogeneic T cells with or without MSCs for 3 days.
BM-MSCs could be differentiated in vitro into osteogenic, chondrogenic and adipogenic lineages. DP-MSCs showed osteogenic and adipocytic differentiation, but did not differentiate into chondrocytes. Although DP-MSCs grow rapidly in vitro between day 3 and day 8 of culture and then decrease their proliferation by day 15, BM-MSCs have a stable and continuous proliferation over the same period of time. The addition of DP-MSCs or BM-MSCs resulted in 91 +/- 4% and 75 +/- 3% inhibition of T cell response, respectively, assessed by a 3H-thymidine assay.
Dental pulp is an easily accessible and efficient source of MSCs, with different kinetics and differentiation potentialities from MSCs as isolated from the bone marrow. The rapid proliferative capacity together with the immunoregulatory characteristics of DP-MSCs may prompt future studies aimed at using these cells in the treatment or prevention of T-cell alloreactivity in hematopoietic or solid organ allogeneic transplantation.
由于骨髓间充质干细胞(MSCs)具有多能分化能力或免疫抑制功能,目前正处于临床前和临床研究阶段。本研究的目的是评估牙髓(DP)作为MSCs的潜在来源而非骨髓(BM)的可能性。
流式细胞术分析显示,牙髓间充质干细胞和骨髓间充质干细胞SH2、SH3、SH4、CD29和CD166均呈阳性。通过3H-胸腺嘧啶核苷掺入摄取法测量间充质干细胞的体外增殖动力学。然后通过将PHA刺激的同种异体T细胞与间充质干细胞共培养3天来测试间充质干细胞的免疫抑制功能,共培养分有间充质干细胞组和无间充质干细胞组。
骨髓间充质干细胞可在体外分化为成骨、成软骨和脂肪生成谱系。牙髓间充质干细胞表现出成骨和脂肪细胞分化,但未分化为软骨细胞。虽然牙髓间充质干细胞在培养的第3天到第8天在体外快速生长,然后在第15天增殖减缓,但骨髓间充质干细胞在同一时期具有稳定且持续的增殖。通过3H-胸腺嘧啶核苷测定法评估,添加牙髓间充质干细胞或骨髓间充质干细胞分别导致T细胞反应抑制91±4%和75±3%。
牙髓是一种易于获取且高效的间充质干细胞来源,其动力学和分化潜能与从骨髓中分离的间充质干细胞不同。牙髓间充质干细胞的快速增殖能力以及免疫调节特性可能促使未来开展旨在将这些细胞用于治疗或预防造血或实体器官同种异体移植中T细胞同种异体反应性的研究。